Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Purpose

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

Condition

  • Glaucoma

Eligibility

Eligible Ages
Over 35 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of primary open-angle glaucoma - Phakic or pseudophakic - Age 35 years or older

Exclusion Criteria

  • Traumatic, uveitic, neovascular, angle-closure glaucoma or - glaucoma associated with vascular disorders - Active corneal inflammation or edema - Retinal disorders not associated with glaucoma

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
iStent Infinite 		iStent Infinite Trabecular Micro-Bypass System
  • Device: iStent Infinite
    iStent Infinite Trabecular Micro-Bypass System

Recruiting Locations

Glaukos Investigator Site
Cincinnati, Ohio 45242
Contact:
Dari Parizadeh

More Details

Status
Recruiting
Sponsor
Glaukos Corporation

Study Contact

Dari Parizadeh
949-481-0575
dparizadeh@glaukos.com